insights_auto
Why is ALK-B down 2,37%?
Dive Deeperchevron_right
ALK-B:CPH
ALK-Abello A/S
DKK 239,20
arrow_downward
-2,37%(-5,80) 1D
20 Nov., 17:00:00 GMT+1 · DKK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALK-B...
Open
DKK 243,80
High
DKK 244,00
Low
DKK 238,60
Mkt. cap
49,63 mjd.
Avg. vol.
203,93 k
Volume
185,88 k
52-wk high
DKK 271,40
52-wk low
DKK 191,80
Shares outstanding
202,57 m.
No. of employees
3 k
Open
DKK 243,80
High
DKK 244,00
Low
DKK 238,60
Mkt. cap
49,63 mjd.
Avg. vol.
203,93 k
Volume
185,88 k
52-wk high
DKK 271,40
52-wk low
DKK 191,80
Shares outstanding
202,57 m.
No. of employees
3 k
News stories
From web sources and news partners
GuruFocus
·
2 dae gelede
ALK-Abelló A/S Reports Strong Q3 Results, Shares Trade Modestly Above GF Value™ (AKBLF)
www.tokenpost.com
·
2 dae gelede
ALK-Abelló A/S Q3 Revenue Rises 15% to DKK 1.76 Billion
TradingView
·
3 dae gelede
ALK_B: Tablet-led growth lifted Q3 revenue 15%; FY guidance holds at 16–17% growth
Profile
ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. It is one of the world's largest makers of allergy immunotherapy products with 67% of its revenue coming from sales in Europe. Wikipedia
About ALK-Abello A/S
CEOPeter J. Halling
Employees2,8 k
Founded1923
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitealk.net